Safety and Efficacy of Beclomethasone Dipropionate in Patients At Least 12 Years Old With Asthma
- Study Title
- A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
- Teva Identifier
- BDB-AS-304
- ClinicalTrials.gov Identifier
- NCT02040779
- Study Status
- Completed
- Trial Condition(s)
- Persistent Asthma
- Interventions
- Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- December 26, 2013 - December 24, 2014
- Phase
- Phase 3